Taiwan FDA registration 4254c1452547c49f2bc23fcc8dee5191

"Siemens Atellica" α1-Acid Glycoprotein (AAG) (Non-sterile)

TW: "西門子" α1-酸性醣化蛋白質試劑組 (未滅菌)
Taiwan flagTaiwan·Risk Class 1·MD·RANDOX LABORATORIES LIMITED·Registered Nov 30, 2017 – Nov 30, 2027Active
Registration details
Analysis ID
4254c1452547c49f2bc23fcc8dee5191
License Form
Ministry of Health Medical Device Import No. 018560
Customs Code
DHA09401856005
Company information
Manufacturer Country
United Kingdom
Authorized Representative
SIEMENS HEALTHCARE LIMITED
Product details
Intended Use
Limited to the first level identification range of the medical device management method α-1-glycoprotein immunoassay system (C.5420).
Product Type (Level 1)
C Immunology and microbiology devices
Product Type (Level 2)
C5420 α-1-glycoprotein immunoassay system
Import Information
Imported from abroad
Dates and status
Registration Date
Nov 30, 2017
Expiry Date
Nov 30, 2027
About this record

Access comprehensive regulatory information for "Siemens Atellica" α1-Acid Glycoprotein (AAG) (Non-sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 4254c1452547c49f2bc23fcc8dee5191 and manufactured by RANDOX LABORATORIES LIMITED. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices